|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/232 | |||
| A61K 31/7024 | |||
| A61P 9/00 | |||
| A61P 9/14 |
| (11) | Patento numeris | 2830602 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13712624.9 |
| Europos patento paraiškos padavimo data | 2013-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030211 |
| Data | 2013-03-11 |
| (87) | Numeris | WO 2013/148136 |
| Data | 2013-10-03 |
| (30) | Numeris | Data | Šalis |
| 201261618161 P | 2012-03-30 | US |
| (72) |
SANCILIO, Frederick, US
PERSICANER, Peter, US
CACACE, Janice, US
DAHIM, Mohand, US
|
| (73) |
Omega Biopharma, Inc. ,
345 Hill Avenue, Nashville, TN 37210,
US
|
| (54) | OMEGA-3 FATTY ACID ESTER COMPOSITIONS |
| OMEGA-3 FATTY ACID ESTER COMPOSITIONS |